Danmark fandt, at det foreslåede testprogram til påvisning af fravær af fremmede agenser ikke var tilstrækkeligt til at sikre, at Bovilis BVD/ Bovilis BVD- MD ikke ville gribe ind i landets nationale program til udryddelse af visse sygdomme hos dyr, og at benefit/ risk- forholdet for Bovilis BVD/ Bovilis BVD- MD følgelig var negativt, således at en godkendelse af produktet ville udgøre en potentiel alvorlig risiko for dyrs sundhed.
Denmark considered that the proposed testing regime to demonstrate freedom from extraneous agents was insufficient to ensure that Bovilis BVD/ Bovilis BVD-MD would not interfere with their national eradication campaigns for certain animal diseases and that, therefore, the benefit/ risk assessment for Bovilis BVD/ Bovilis BVD-MD was unfavourable, authorisation of the product representing a potential serious risk to animal health.